[Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].
The authors provide the results of a comparative study into the action of different drug approaches to the prevention of relapses of affective and schizoaffective psychoses with the aid of multifactorial consideration of different clinical, economic and socioeconomic indicators characterizing the "benefits and losses" because of the use of carbamazepine and lithium carbonate. The comparative analysis has shown a high normothymic activity of carbamazepine and lithium carbonate in the patients examined, with the preventive action of carbamazepine being more remarkable as regards the economic and clinical indicators.
Ushakov
Iu V
IuV
Kostiukova
E G
EG
Kalugina
L I
LI
Mirzoian
M G
MG
D000328:Adult; D000368:Aged; D002220:Carbamazepine / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy / Q000191:economics; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000191:economics; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D016651:Lithium Carbonate; D002220:Carbamazepine; D008094:Lithium
Sravnitel'naia otsenka klinicheskoĭ i ékonomicheskoĭ éffektiv- nosti profilakticheskoĭ terapii affektivnykh i shizoaffektivnykh psikhozov.